Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Flexion Therapeutics Inc | flxn-ex322_9.htm |
| EX-32.1 - EX-32.1 - Flexion Therapeutics Inc | flxn-ex321_6.htm |
| EX-31.2 - EX-31.2 - Flexion Therapeutics Inc | flxn-ex312_8.htm |
| EX-31.1 - EX-31.1 - Flexion Therapeutics Inc | flxn-ex311_10.htm |
| EX-21.1 - EX-21.1 - Flexion Therapeutics Inc | flxn-ex211_14.htm |
| EX-10.17 - EX-10.17 - Flexion Therapeutics Inc | flxn-ex1017_72.htm |
| 10-K - 10-K - Flexion Therapeutics Inc | flxn-10k_20201231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-248749) and Form S-8 (Nos. 333-237132, 333-193907, 333-202957, 333-210111, 333-216615, 333-221373, 333-223532 and 333-229969) of Flexion Therapeutics, Inc. of our report dated March 10, 2021 relating to the financial statements, which appears in this Form 10-K.
|
/s/ PricewaterhouseCoopers LLP |
|
Boston, Massachusetts |
|
March 10, 2021 |